share_log

B. Riley Securities Maintains Buy on Journey Medical, Raises Price Target to $6

B. Riley Securities Maintains Buy on Journey Medical, Raises Price Target to $6

B. Riley Securities维持对Journey Medical的买入,将目标股价提高
Benzinga ·  2023/07/12 10:47

B. Riley Securities analyst Kalpit Patel maintains Journey Medical (NASDAQ:DERM) with a Buy and raises the price target from $3 to $6.

莱利证券分析师卡尔皮特·帕特尔维持纳斯达克(JD:DEM)的买入,并将目标价从3美元上调至6美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发